Innovations and challenges in renal cancer: Summary statement from the Third Cambridge Conference
Year: 2009
Type: article
Abstract: The Third Cambridge Conference on Innovations and Challenges in Renal Cancer, a symposium held in Cambridge, Massachusetts, June 27-28, 2008, and chaired by Michael B. Atkins, was convened to discuss the current state of knowledge in the field, critique new data, stimulate communication among those involved in basic and clinical research, and offer recommendations for further study. Four main topics were discussed: genetics and molecular biology of renal cell cancer, staging and prognosis, systemic therapy, and correlative science and biomarkers in stage IV disease. The conference format combined brief presentations with extended periods of discussion. The conclusions and recommendations are summarized in this paper and presented in more detail in the individual papers that follow.
Source: Cancer
DOI: 10.1002/cncr.24229
Authors: Michael B. Atkins, Ronald M. Bukowski, Bernard J. Escudier, Robert A. Figlin, Gary H. Hudes, William G. Kaelin, W. Marston Linehan, David F. McDermott, James W. Mier, Ivan Pedrosa, Brian I. Rini, Sabina Signoretti, Jeffrey A. Sosman, Bin Tean Teh, Christopher G. Wood, Amado J. Zurita, Laura King
Institutions: Beth Israel Deaconess Medical Center, Harvard University, Cleveland Clinic, Institut Gustave Roussy, City Of Hope National Medical Center, City of Hope, Fox Chase Cancer Center, Howard Hughes Medical Institute, National Institutes of Health, National Cancer Institute, Brigham and Women's Hospital, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Van Andel Institute, The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: National Institutes of Health
Award: G9000352505
OpenAlex ID: W1970171529